EY-Biotechnology-Report

The auditing company EY puts together figures and facts for the biotechnology industry in their annual reports. The resulting analyzes are an important contribution to the status quo and potential of German ...

Atriva receives seed financing to develop its next generation influenza therapeutic

14.02.2017 | The next generation of Antiviral Therapies: Led by Stichting Participatie Atriva together with High-Tech Gründerfonds (HTGF), Atriva Therapeutics ...

CureVac’s CEO, Ingmar Hoerr, Appointed by European Commission to High Level Group

23.01.2017 | CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announced that the European Commission has ...

Understand industries, connect industries

17.01.2017 | Dr. Verena Grimm joined the BioRegio STERN Management GmbH team as a project manager in January 2017. The biotechnologist completed a tri-national degree course in Germany, Switzerland and ...